Ramsay Santé Proposes Frédéric Collet as Independent Chairman After RHC Distribution
Bitget2026/10/19 06:32- Ramsay Santé proposes Frédéric Collet, former president of Novartis France, as independent chairman.
- CEO Pascal Roché and Alexandra Boleslawski, Crédit Agricole Group’s chief risk officer from 2019 to 2025, are proposed as directors.
- The appointments require shareholder approval on December 4, 2026, and completion of Ramsay Health Care’s planned share distribution.
- The distribution of Ramsay Health Care’s 52.79% stake is scheduled for December 9, 2026, subject to shareholder approval and required authorizations.
- Chairwoman Natalie Davis and four other RHC-nominated directors will resign upon completion; the resulting board is expected to have an independent majority.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Adidas achieves record revenue in the third quarter, with Greater China growing by 13%, signaling channel expansion
Adidas has continued its growth momentum in the Chinese market, with channel partners beginning to show a stronger willingness to expand stores. On October 29, Adidas released...
The Bank of Japan keeps its benchmark interest rate unchanged at 1.25%, warns of increasing risks of inflation overshooting, and maintains a gradual rate hike stance.
The Bank of Japan stated that core inflation has reached a level consistent with its price target and is expected to remain around this level. Medium- and long-term inflation expectations are maintained at approximately 2%. The central bank also emphasized the need to pay special attention to the risk of inflation deviating upward and becoming a reality.
User growth hits record high in Q3, but revenue "loses steam": Citi maintains neutral rating on Pinterest (PINS.US)
Pinterest's Q3 revenue and profits fell short of expectations, with weak monetization in Europe dragging down guidance. Citi maintains a neutral rating with a target price of $27.
Crypto prices
More
